" class="no-js "lang="en-US"> Partnerships Archives - Page 46 of 52 - Medtech Alert
Tuesday, September 30, 2025

Sort by:

Date

Top Post

ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients

ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]

Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases

Amgen (NASDAQ: AMGN) and Neumora Therapeutics, Inc. (Neumora), a clinical-stage biopharmaceutical company pioneering precision medicines for […]

Röchling Medical and Trendlines Innovation Labs Join Forces to Offer Top Innovation and Manufacturing Expertise to the Healthcare Industry

Röchling Medical, a division of the German-based Röchling Group and a leading manufacturer for the healthcare […]

C-RAD and Accuray Sign Agreement to Enhance Radixact® System Breast Cancer Treatment Capabilities

C-RAD AB (NASDAQ Stockholm: CRAD B) and Accuray Incorporated (NASDAQ: ARAY) announced today they have signed […]

Avacta Group Achievement of Pre-clinical Development Milestone in LG Chem Life Sciences Partnership

Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and […]

LTI and eClinicalHealth Form Strategic Partnership to Accelerate Innovation in Clinical Research

Larsen & Toubro Infotech (BSE: 540005, NSE: LTI), a global technology consulting and digital solutions company […]

ViroCell Biologics and Great Ormond Street Hospital for Children Announce Partnership to Dislodge Gene and Cell Therapy “Logjam”

ViroCell Biologics (“ViroCell”), founded by the UK’s most prolific academic viral vector manufacturing team, and […]

Vytal Partners with GenieMD to Provide Telehealth Services on Prescription Management and Delivery Platform

Vytal, a healthcare technology company, today announced a national collaboration with GenieMD, a global provider of […]

VaxEquity Announces Strategic Collaboration with AstraZeneca to Commercialise Self-Amplifying RNA Platform

VaxEquity, developing transformative RNA vaccines and therapeutics based on its next generation self-amplifying RNA (saRNA) […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more